Annual Retained Earnings
-$377.94 M
-$85.89 M-29.41%
31 December 2023
Summary:
Viking Therapeutics annual retained earnings is currently -$377.94 million, with the most recent change of -$85.89 million (-29.41%) on 31 December 2023. During the last 3 years, it has fallen by -$209.75 million (-124.71%). VKTX annual retained earnings is now -340390.09% below its all-time high of -$111.00 thousand, reached on 31 December 2012.VKTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$452.49 M
-$24.94 M-5.83%
30 September 2024
Summary:
Viking Therapeutics quarterly retained earnings is currently -$452.49 million, with the most recent change of -$24.94 million (-5.83%) on 30 September 2024. Over the past year, it has dropped by -$99.15 million (-28.06%). VKTX quarterly retained earnings is now -92966.64% below its all-time high of -$486.20 thousand, reached on 31 March 2014.VKTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.4% | -28.1% |
| 3 y3 years | -124.7% | -114.6% |
| 5 y5 years | -267.2% | -273.2% |
VKTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -124.7% | at low | -114.6% | at low |
| 5 y | 5 years | -267.2% | at low | -273.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Viking Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$452.49 M(+5.8%) |
| June 2024 | - | -$427.55 M(+5.5%) |
| Mar 2024 | - | -$405.30 M(+7.2%) |
| Dec 2023 | -$377.94 M(+29.4%) | -$377.94 M(+7.0%) |
| Sept 2023 | - | -$353.34 M(+6.8%) |
| June 2023 | - | -$330.81 M(+6.2%) |
| Mar 2023 | - | -$311.58 M(+6.7%) |
| Dec 2022 | -$292.05 M(+30.9%) | -$292.05 M(+7.2%) |
| Sept 2022 | - | -$272.49 M(+6.1%) |
| June 2022 | - | -$256.72 M(+7.3%) |
| Mar 2022 | - | -$239.28 M(+7.2%) |
| Dec 2021 | -$223.18 M(+32.7%) | -$223.18 M(+5.9%) |
| Sept 2021 | - | -$210.83 M(+6.7%) |
| June 2021 | - | -$197.58 M(+8.4%) |
| Mar 2021 | - | -$182.20 M(+8.3%) |
| Dec 2020 | -$168.19 M(+30.7%) | -$168.19 M(+7.0%) |
| Sept 2020 | - | -$157.24 M(+6.3%) |
| June 2020 | - | -$147.96 M(+6.9%) |
| Mar 2020 | - | -$138.38 M(+7.5%) |
| Dec 2019 | -$128.70 M | -$128.70 M(+6.1%) |
| Sept 2019 | - | -$121.25 M(+5.0%) |
| June 2019 | - | -$115.52 M(+7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$107.84 M(+4.8%) |
| Dec 2018 | -$102.92 M(+27.3%) | -$102.92 M(+5.4%) |
| Sept 2018 | - | -$97.68 M(+7.2%) |
| June 2018 | - | -$91.08 M(+7.9%) |
| Mar 2018 | - | -$84.41 M(+4.4%) |
| Dec 2017 | -$80.86 M(+34.1%) | -$80.86 M(+5.3%) |
| Sept 2017 | - | -$76.77 M(+8.6%) |
| June 2017 | - | -$70.67 M(+7.9%) |
| Mar 2017 | - | -$65.50 M(+8.7%) |
| Dec 2016 | -$60.28 M(+32.3%) | -$60.28 M(+6.4%) |
| Sept 2016 | - | -$56.63 M(+7.2%) |
| June 2016 | - | -$52.83 M(+7.5%) |
| Mar 2016 | - | -$49.13 M(+7.9%) |
| Dec 2015 | -$45.55 M(+105.7%) | -$45.55 M(+12.6%) |
| Sept 2015 | - | -$40.45 M(+13.3%) |
| June 2015 | - | -$35.72 M(+28.2%) |
| Mar 2015 | - | -$27.85 M(+25.8%) |
| Dec 2014 | -$22.14 M(+8505.3%) | -$22.14 M(-4.8%) |
| June 2014 | - | -$23.27 M(+4685.9%) |
| Mar 2014 | - | -$486.20 K |
| Dec 2013 | -$257.30 K(+131.8%) | - |
| Dec 2012 | -$111.00 K | - |
FAQ
- What is Viking Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Viking Therapeutics?
- What is Viking Therapeutics annual retained earnings year-on-year change?
- What is Viking Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Viking Therapeutics?
- What is Viking Therapeutics quarterly retained earnings year-on-year change?
What is Viking Therapeutics annual retained earnings?
The current annual retained earnings of VKTX is -$377.94 M
What is the all time high annual retained earnings for Viking Therapeutics?
Viking Therapeutics all-time high annual retained earnings is -$111.00 K
What is Viking Therapeutics annual retained earnings year-on-year change?
Over the past year, VKTX annual retained earnings has changed by -$85.89 M (-29.41%)
What is Viking Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VKTX is -$452.49 M
What is the all time high quarterly retained earnings for Viking Therapeutics?
Viking Therapeutics all-time high quarterly retained earnings is -$486.20 K
What is Viking Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VKTX quarterly retained earnings has changed by -$99.15 M (-28.06%)